Inducing GSK-3β Ser-9 phosphorylation through AMPK, a kinase, liberates NRF2 and improves cognitive impairment and pathological features in Alzheimer’s disease (63). The gene discussed is NFE2L2; the disease is early-onset autosomal dominant Alzheimer disease.